Open-label Extension Study of ADP101

Stopped early · Phase 1/Phase 2

Conditions studied: Food Allergy

In brief

This is an open-label, safety extension study for participants who participated in the Harmony study (protocol ADP101-MA-01).

Key facts

Study ID

NCT05243719

Run by

Alladapt Immunotherapeutics, Inc.

People needed

45

Starts

2022-03-14

Expected to finish

2024-02-27

Last updated by the study team

2024-03-26

Who can join

Age: 4 and older, up to 57. Sex: any. Healthy volunteers: not accepted.

Where it is running

• Study Site — Mission Viejo, California, United States
• Study Site — Rolling Hills Estates, California, United States
• Study Site — San Diego, California, United States
• Study Site — Colorado Springs, Colorado, United States
• Study Site — Denver, Colorado, United States
• Study Site — Tampa, Florida, United States
• Study Site — Atlanta, Georgia, United States
• Study Site — Marietta, Georgia, United States
• Study Site — Normal, Illinois, United States
• Study Site — Ann Arbor, Michigan, United States
• Study Site — Chapel Hill, North Carolina, United States
• Study Site — Cincinnati, Ohio, United States
• Study Site — Charleston, South Carolina, United States
• Study Site — Seattle, Washington, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.